Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

138 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Outcome of allo-SCT for chronic myelomonocytic leukemia.
Ocheni S, Kröger N, Zabelina T, Zander AR, Bacher U. Ocheni S, et al. Among authors: zabelina t. Bone Marrow Transplant. 2009 Apr;43(8):659-61. doi: 10.1038/bmt.2008.366. Epub 2008 Nov 10. Bone Marrow Transplant. 2009. PMID: 18997830 No abstract available.
Evaluation of BM cytomorphology after allo-SCT in patients with AML.
Christopeit M, Miersch K, Klyuchnikov E, Haferlach T, Binder M, Zabelina T, Ayuk F, Schafhausen P, Zander AR, Bokemeyer C, Kröger N, Bacher U. Christopeit M, et al. Among authors: zabelina t. Bone Marrow Transplant. 2012 Dec;47(12):1538-44. doi: 10.1038/bmt.2012.70. Epub 2012 Apr 30. Bone Marrow Transplant. 2012. PMID: 22543745
Evaluation of BM cytomorphology after allo-SCT in patients with MDS.
Christopeit M, Ocheni S, Haferlach T, Miersch K, Zabelina T, Klyuchnikov E, Binder M, Ayuk F, Schafhausen P, Zander AR, Bokemeyer C, Kröger N, Bacher U. Christopeit M, et al. Among authors: zabelina t. Bone Marrow Transplant. 2013 Mar;48(3):465-6. doi: 10.1038/bmt.2012.161. Epub 2012 Sep 3. Bone Marrow Transplant. 2013. PMID: 22941378 No abstract available.
Donor choice according to age for allo-SCT for AML in complete remission.
Ayuk F, Zabelina T, Wortmann F, Alchalby H, Wolschke C, Lellek H, Bacher U, Zander A, Kröger N. Ayuk F, et al. Among authors: zabelina t. Bone Marrow Transplant. 2013 Aug;48(8):1028-32. doi: 10.1038/bmt.2013.14. Epub 2013 Feb 18. Bone Marrow Transplant. 2013. PMID: 23419435
Dose-dependent effect of etoposide in combination with busulfan plus cyclophosphamide as conditioning for stem cell transplantation in patients with acute myeloid leukemia.
Kröger N, Zabelina T, Sonnenberg S, Krüger W, Renges H, Stute N, Finkenstein F, Mayer U, Holstein K, Fiedler W, Colberg H, Sonnen R, Kuse R, Braumann D, Metzner B, del Valle F, Erttmann R, Kabisch H, Zander AR. Kröger N, et al. Among authors: zabelina t. Bone Marrow Transplant. 2000 Oct;26(7):711-6. doi: 10.1038/sj.bmt.1702598. Bone Marrow Transplant. 2000. PMID: 11042650
In vivo T cell depletion with pretransplant anti-thymocyte globulin reduces graft-versus-host disease without increasing relapse in good risk myeloid leukemia patients after stem cell transplantation from matched related donors.
Kröger N, Zabelina T, Krüger W, Renges H, Stute N, Rischewski J, Sonnenberg S, Ayuk F, Tögel F, Schade U, Fiegel H, Erttmann R, Löliger C, Zander AR. Kröger N, et al. Among authors: zabelina t. Bone Marrow Transplant. 2002 Apr;29(8):683-9. doi: 10.1038/sj.bmt.1703530. Bone Marrow Transplant. 2002. PMID: 12180114
138 results